Outward-and inward-facing structures of a putative bacterial transition-metal transporter with homology to ferroportin

Nature Communications

Volumn 6, Issue , 2015, Pages

  Taniguchi, Reiya ^a,b   Kato, Hideaki E ^a,b,e   Font, Josep ^c,d   Deshpande, Chandrika N ^c,d   Wada, Miki ^a   Ito, Koichi ^a   Ishitani, Ryuichiro ^a,b   Jormakka, Mika ^c,d   Nureki, Osamu ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN   (Japan)

^c CENTENARY INSTITUTE   (Australia)

^d University of Sydney   (Australia)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC ION; FERROPORTIN; HEPCIDIN; PEPTIDE HORMONE; TRANSITION ELEMENT; CATION TRANSPORT PROTEIN; IRON; METAL TRANSPORTING PROTEIN 1;

CELLS AND CELL COMPONENTS; HOMEOSTASIS; HOMOLOGY; IRON; MUTATION; PROTEIN; VERTEBRATE;

ARTICLE; BDELLOVIBRIO; BDELLOVIBRIO BACTERIOVORUS; BINDING SITE; CHRONIC INFLAMMATION; COMPARATIVE STUDY; CONTROLLED STUDY; CRYSTAL STRUCTURE; HOMEOSTASIS; IRON TRANSPORT; METAL BINDING; NONHUMAN; PROTEIN STRUCTURE; REGULATORY MECHANISM; CHEMISTRY; HUMAN; METABOLISM; PROTEIN CONFORMATION; STRUCTURAL HOMOLOGY;

BACTERIA (MICROORGANISMS); VERTEBRATA;

BDELLOVIBRIO; BINDING SITES; CATION TRANSPORT PROTEINS; HUMANS; IRON; PROTEIN CONFORMATION; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 84944111628     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9545     Document Type: Article

References (51)

1. McKie, A. T. et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5, 299-309 (2000).
2. Donovan, A. et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776-781 (2000).
3. Abboud, S., Haile, D. J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275, 19906-19912 (2000).
4. Yang, F. et al. Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J. Biol. Chem. 277, 39786-39791 (2002).
5. Hentze, M. W., Muckenthaler, M. U., Galy, B., Camaschella, C. Two to tango: regulation of mammalian iron metabolism. Cell 142, 24-38 (2010).
6. Donovan, A. et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1, 191-200 (2005).
7. Détivaud, L. et al. Ferroportin diseases: functional studies, a link between genetic and clinical phenotype. Hum. Mutat. 34, 1529-1536 (2013).
8. Pietrangelo, A., Caleffi, A., Corradini, E. Non-HFE hepatic iron overload. Semin. Liver Dis. 31, 302-318 (2011).
9. Nemeth, E. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093 (2004).
10. Jordan, J. B. et al. Hepcidin revisited, disulfide connectivity, dynamics, and structure. J. Biol. Chem. 284, 24155-24167 (2009).
11. Ramos, E. et al. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology 53, 1333-1341 (2011).
12. Ross, S. L. et al. Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metab. 15, 905-917 (2012).
13. Qiao, B. et al. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab. 15, 918-924 (2012).
14. Nemeth, E. et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113, 1271-1276 (2004).
15. Ganz, T., Nemeth, E. Hepcidin and disorders of iron metabolism. Annu. Rev. Med. 62, 347-360 (2011).
16. Jankowska, E. A., von Haehling, S., Anker, S. D., Macdougall, I. C., Ponikowski, P. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur. Heart J. 34, 816-829 (2013).
17. Origa, R. et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica 92, 583-588 (2007).
18. Liu, X.-B., Yang, F., Haile, D. J. Functional consequences of ferroportin 1 mutations. Blood Cells Mol. Dis. 35, 33-46 (2005).
19. Wallace, D. F., Harris, J. M., Subramaniam, V. N. Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype. Am. J. Physiol. Cell Physiol. 298, C75-C84 (2010).
20. Le Gac, G. et al. Structure-function analysis of the human ferroportin iron exporter (SLC40A1): effect of hemochromatosis type 4 disease mutations and identification of critical residues. Hum. Mutat. 34, 1371-1380 (2013).
21. Bonaccorsi di Patti, M. C. et al. A structural model of human ferroportin and of its iron binding site. FEBS J. 281, 2851-2860 (2014).
22. Callebaut, I. et al. Comprehensive functional annotation of 18 missense mutations found in suspected hemochromatosis type 4 patients. Hum. Mol. Genet. 23, 4479-4490 (2014).
23. Kawate, T., Gouaux, E. Fluorescence-detection size-exclusion chromatography for precrystallization screening of integral membrane proteins. Structure 14, 673-681 (2006).
24. Ehrnstorfer, I. A., Geertsma, E. R., Pardon, E., Steyaert, J., Dutzler, R. Crystal structure of a SLC11 (NRAMP) transporter reveals the basis for transitionmetal ion transport. Nat. Struct. Mol. Biol. 21, 990-996 (2014).
25. Mitchell, C. J., Shawki, A., Ganz, T., Nemeth, E., Mackenzie, B. Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc. Am. J. Physiol. Cell Physiol. 306, C450-C459 (2014).
26. Madejczyk, M. S., Ballatori, N. The iron transporter ferroportin can also function as a manganese exporter. Biochim. Biophys. Acta 1818, 651-657 (2012).
27. Caffrey, M., Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nat. Protoc. 4, 706-731 (2009).
28. Cherezov, V. Lipidic cubic phase technologies for membrane protein structural studies. Curr. Opin. Struct. Biol. 21, 559-566 (2011).
29. Shi, Y. Common folds and transport mechanisms of secondary active transporters. Annu. Rev. Biophys. 42, 51-72 (2013).
30. Yan, N. Structural advances for the major facilitator superfamily (MFS) transporters. Trends Biochem. Sci. 38, 151-159 (2013).
31. Dang, S. et al. Structure of a fucose transporter in an outward-open conformation. Nature 467, 734-738 (2010).
32. Doki, S. et al. Structural basis for dynamic mechanism of proton-coupled symport by the peptide transporter POT. Proc. Natl Acad. Sci. USA 110, 11343-11348 (2013).
33. Yan, H. et al. Structure and mechanism of a nitrate transporter. Cell Rep. 3, 716-723 (2013).
34. Pedersen, B. P. et al. Crystal structure of a eukaryotic phosphate transporter. Nature 496, 533-536 (2013).
35. Harding, M. M. Small revisions to predicted distances around metal sites in proteins. Acta Crystallogr. D. Biol. Crystallogr. 62, 678-682 (2006).
36. Shannon, R. D. Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides. Acta Crystallogr. A 32, 751-767 (1976).
37. Fukuda, M. et al. Structural basis for dynamic mechanism of nitrate/nitrite antiport by NarK. Nat. Commun. 6, 7097 (2015).
38. Gunshin, H. et al. Cloning and characterization of a mammalian protoncoupled metal-ion transporter. Nature 388, 482-488 (1997).
39. Preza, G. C. et al. Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J. Clin. Invest. 121, 4880-4888 (2011).
40. Mayr, R. et al. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload. Gastroenterology 140, 2056-2063 (2011).
41. Fernandes, A. et al. The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 114, 437-443 (2009).
42. Waldo, G. S., Standish, B. M., Berendzen, J., Terwilliger, T. C. Rapid protein-folding assay using green fluorescent protein. Nat. Biotechnol. 17, 691-695 (1999).
43. Hirata, K. et al. Achievement of protein micro-crystallography at SPring-8 beamline BL32XU. J. Phys. Conf. Ser. 425, 012002 (2013).
44. Kabsch, W. XDS. Acta Crystallogr. D. Biol. Crystallogr. 66, 125-132 (2010).
45. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. A 64, 112-122 (2008).
46. Vonrhein, C., Blanc, E., Roversi, P., Bricogne, G. Automated structure solution with autoSHARP. Methods Mol. Biol. 364, 215-230 (2007).
47. Terwilliger, T. C. et al. Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr. D. Biol. Crystallogr. 64, 61-69 (2008).
48. Emsley, P., Lohkamp, B., Scott, W. G., Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486-501 (2010).
49. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213-221 (2010).
50. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 (2007).
51. Sali, A., Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815 (1993).